Lens Handling on Removal
Primary
· Collected once on day 6 at the end of wear
Ease of lens removal on a 0-100 scale (0= very difficult, 100= very easy)
| Group | Value | 95% CI |
|---|---|---|
| Control Lens | 90 | ± 18 |
| Test Lens | 95 | ± 8 |
Last reviewed · How we verify
NCT05805150
Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently
Completed
NA
Results posted
Last updated 25 June 2024
What this trial tests
NA trial testing Control Lens (stenfilcon A) in Myopia in 69 participants. Completed in 1 June 2023.
Timeline
13 March 2023
Primary endpoint
1 June 2023
1 June 2023
1 June 2023
Quick facts
| Lead sponsor | CooperVision, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 69 |
| Start date | 13 March 2023 |
| Primary completion | 1 June 2023 |
| Estimated completion | 1 June 2023 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Control Lens (stenfilcon A)
- Test Lens (senofilcon A)
Conditions studied
- Myopia — all drugs for Myopia →
Sponsor
CooperVision, Inc.
Who can join
Adults 18 to 35, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Adverse events — posted to ClinicalTrials.gov
Time frame: Duration of the study, approximately 2 weeks.. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Control Lens
Serious: 0/69 (0%)
Deaths: 0/69
Test Lens
Serious: 0/69 (0%)
Deaths: 0/69
Other adverse events (2 terms — click to expand)
| Reaction | System | Control Lens | Test Lens |
|---|---|---|---|
| Redness and Swelling | Eye disorders | — | — |
| Redness and small bump on lid | Eye disorders | — | — |
Data from ClinicalTrials.gov NCT05805150 adverse events section.
Sponsor's own description
The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05805150
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Control Lens (stenfilcon A)
Trials testing the same drug.
- NCT05763628 — Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses · NA · completed
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other CooperVision, Inc. trials
Trials by the same sponsor.
- NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
- NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
- NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
- NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
- NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT05805150 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
- Last refreshed: 25 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05805150.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing